Structure elucidation and degradation kinetic study of Ofloxacin using surface enhanced Raman spectroscopy

被引:25
作者
El-Zahry, Marva R. [1 ]
Lendl, Bernhard [2 ]
机构
[1] Assiut Univ, Dept Pharmaceut Analyt Chem, Fac Pharm, Assiut 71526, Egypt
[2] Vienna Univ Technol, Inst Chem Technol & Analyt, Getreidemarkt 9-151, A-1060 Vienna, Austria
关键词
Ofloxacin; Stability indicating analysis; SERS; Structure elucidation; Kinetic study; BETA-CYCLODEXTRIN; HPLC METHOD; CHEMILUMINESCENCE; FLUOROQUINOLONES; FLUORESCENCE; ELECTRODE; ACID; FILM; NANOPARTICLES; MOXIFLOXACIN;
D O I
10.1016/j.saa.2017.12.007
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
A simple, fast and sensitive surface enhanced Raman spectroscopy (SERS) method for quantitative determination of fluoroquinolone antibiotic Ofloxacin (OFX) is presented. Also the stability behavior of OFX was investigated by monitoring the SERS spectra of OFX after various degradation processes. Acidic, basic and oxidative force degradation processes were applied at different time intervals. The forced degradation conditions were conducted and followed using SERS method utilizing silver nanoparticles (Ag NPs) as a SERS substrate. The Ag NPs colloids were prepared by reduction of silver nitrate using polyethyelene glycol (PEG) as a reducing and stabilizing agent. Validation tests were done in accordance with International Conference on Harmonization (ICH) guidelines. The calibration curve with a correlation coefficient (R = 0.9992) was constructed as a relationship between the concentration range of OFX (100-500 ng/ml) and SERS intensity at 1394 cm(-1) band. LOD and LOQ values were calculated and found to be 23.5 ng/ml and 72.6 ng/ml, respectively. The developed method was applied successfully for quantitation of OFX in different pharmaceutical dosage forms. Kinetic parameters were calculated including rate constant of the degradation of the studied antibiotic. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 39 条
[1]  
Abd-Elgawad R., 2010, The Open Chemical and Biomedical Methods Journal, V3, P27
[2]  
Al-Omar MA, 2009, PROF DRUG SUB EXCIP, V34, P265, DOI [10.1016/S1871-5125(09)34006-6, 10.1016/S0099-5428(08)00006-3]
[3]   Chemiluminescence determination of some fluoroquinolone derivatives in pharmaceutical formulations and biological fluids using [Ru(bipy)23+]-Ce(IV) system [J].
Aly, FA ;
Al-Tamimi, SA ;
Alwarthan, AA .
TALANTA, 2001, 53 (04) :885-893
[4]  
[Anonymous], 1996, ICH HARMONISED TRIPA
[5]  
Ashish P. G., 2016, INT J PHARM TECH RES, V9, P289
[6]   Fourier transform Raman and surface-enhanced Raman spectroscopy of some quinoline derivatives [J].
Bolboaca, M ;
Kiefer, W ;
Popp, J .
JOURNAL OF RAMAN SPECTROSCOPY, 2002, 33 (03) :207-212
[7]  
Challa R, 2016, ANA CHEM INDIAN J, V16, P519
[8]   Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection [J].
Chan, Kwok Ping ;
Chu, Kai On ;
Lai, Wico Wai-Kwan ;
Choy, Kwong Wai ;
Wang, Chi Chiu ;
Lam, Dennis Shun-Chiu ;
Pang, Chi Pui .
ANALYTICAL BIOCHEMISTRY, 2006, 353 (01) :30-36
[9]   Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma [J].
De Smet, Julie ;
Boussery, Koen ;
Colpaert, Kirsten ;
De Sutter, Peter ;
De Paepe, Peter ;
Decruyenaere, Johan ;
Van Bocxlaer, Jan .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (10) :961-967
[10]  
Dharuman J., 2009, Int J PharmTech Res, V1, P121